CASI Pharmaceuticals drops after Nasdaq serves deficiency notice

CASI Pharmaceuticals

03/01/2022 12:45

** Biopharma co's  CASI.O  shares drop 2.5% to 78 cents
premarket
    ** Co says received deficiency letter from Nasdaq on Dec.
30, notifying that for previous 30 consecutive business days,
stock had closed below the minimum $1 price  urn:newsml:reuters.com:*:nPn70pb3na
    ** Letter has no immediate effect on the listing, CASI says
    ** Co says has until June 28 to regain compliance 
    ** Stock lost nearly 77% of its value in 2021

 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com;))